IL22 and autoimmune polyendocrine syndrome type 1: Among the 188 samples from patients in the comparison groups without diagnosed APS-1, exceeding the cut-off value for autoantibodies against either IFN-ω, IFN-α-2a or IL-22 was only revealed in 3 samples (Figure 3).